AI solutions provider for healthcare companies Beamtree Holdings (ASX: BMT) has won a significant contract bid with the Provincial Health Services Authority (PHSA) in British Columbia, Canada. This milestone marks Beamtree’s first major foray into the North American market. The contract, valued at approximately $0.5 million, signifies a pivotal achievement for the Company and is
Read More
As medical technology continues to advance, digital imaging is now a staple for image interpretation for cancer diagnosis, especially in finding potential abnormalities that aren’t visible to the eyes as well as evaluating the extent of the disease. Breast cancer software company Volpara (ASX: VHT) is among those that offers what it takes to meet
Read More
A quick recap for anyone who is out of the crypto whirlpool: Last year, FTX (one of the largest crypto exchanges) collapsed, crypto prices crashed and inflation rose. Now, the US Securities and Exchange Commission (SEC) is suing the world’s largest crypto exchange, Binance, for mishandling consumer funds, misleading consumers and creating a “web of
Read More
Biotech company Avecho (ASX: AVE) has completed the development of its first generation TPM gummies containing cannabinoids and is all set to release them to Aussie consumers. TPM cannabinoid gummies out-perform standard products with faster onset and greater magnitude of effect. Gummies are chewable, jelly-like preparations made from a mixture of glycerin and gelatin, able
Read More
China has emerged as a hotspot for baby formula export from Australia and New Zealand. Imported baby formula holds a significant 56% share of the total market, making it one of the leading export commodities from both countries. These imported formulas will be valued at an estimated US$32 billion by 2023, according to Euromonitor, driven
Read More
Retail pharmacy supplier Sigma Healthcare (ASX: SIG) – the Company behind Amcal and Discount Drug Stores – has struck a deal with pharmacy giant Chemist Warehouse. The deal encompasses the supply of Pharmaceutical Benefits Scheme (PBS) medicines and healthcare products for five years, set to kick off on July 1, 2024. Sigma currently serves as
Read More
Heyday is enjoying its heyday, signing on tech giants as clients once again. In a significant development, electrical engineering company Southern Cross Electrical Engineering (ASX: SXE) subsidiary, Heyday—an electrical installation service, has been awarded three prestigious data centre projects in Sydney. Collectively, they are valued at over $60 million. The projects are poised to reinforce
Read More
In 2020, the Department of Health and Aged Care revealed that approximately 2,000 Australians were diagnosed with brain cancer. New cases of brain cancer are increasing every year and Glioblastoma, the most common, complex, treatment-resistant, and deadliest type of brain cancer, accounts for 45% of all malignant brain tumours. On a global scale, it is
Read More
Biopharmaceutical company Starpharma (ASX: SPL) has received regulatory approval for its antiviral nasal spray product, VIRALEZE, in Malaysia. This milestone achievement grants Starpharma and its commercial partners the opportunity to market and sell the innovative product in Malaysia, a country with a population exceeding 33 million. VIRALEZE has garnered significant recognition in Asia following successful
Read More
As it departs from Australia to cement its base in the UK alone, telehealth company Doctor Care Anywhere Group (ASX: DOC) has decided to sell its Aussie subsidiary GP2U Telehealth. The Company had bought GP2U for $11 million in September 2021 to tap into the mental health market in Australia, which worsened following the pandemic.
Read More
